Treatment with dapagliflozin for 32 weeks following an initial 32-week period of HFD feeding did not attenuate obesity or insulin resistance, however, it did enhance reproductive function, decrease adipocyte hypertrophy, and improve LH release. This evidence concerns the gene PLOD1 and obesity due to melanocortin 4 receptor deficiency.